Abstract
Hemophilia A is an X-linked bleeding disorder caused by a deficiency in blood coagulation factor VIII. Mutations in the F8 gene are responsible for this disease affecting 1 in 5,000 live male births. Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease, also known as Osler-Weber-Rendu disease, associated with abnormal blood vessel formation. It is associated with alterations in at least two genes including Endoglin (ENG) on chromosome 9q34 and activin receptor-like kinase 1 (ACVRL1 or ALK1) on chromosome 12q13, which are involved in cell proliferation, differentiation, migration, and adhesion in the vascular system. Direct sequencing of the coding exons of the relevant genes in affected individuals is the primary screen for detecting a causative point mutation. However for most diseases, 10–15% of mutations involve intragenic deletions, or duplications of the whole gene or a subset of exons of the same gene. This necessitates an additional screen for exonic dosage estimation of all coding sequence mutation negative affected, or, carrier individuals. This is accomplished by using a real-time quantitative PCR assay for measuring the copy number of each exon of the relevant gene. This testing establishes the diagnosis in hemophilia A patients, as well as carrier status in at-risk females. Similarly, it can provide molecular confirmation for clinical diagnosis of HHT, as well as the identification of mutation carriers among presymptomatic individuals when the familial mutation is known.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pagon RA, Bird TD, Dolan CR et al (eds). GeneReviews, http://www.ncbi.nim.nih.gov/books/NBK1404/. Seattle: University of Washington, Seattle; 1993.
Song MJ, Kim HJ, Yoo KY, Park IA, Lee KO, Ki CS, Kim SH. Molecular characterization of female hemophilia A by multiplex ligation-dependent probe amplification analysis and X-chromosome inactivation study. Blood Coagul Fibrinolysis. 2011;22:211–14.
Rossetti LC, Radic CP, Larripa IB, De Brasi CD. Developing a new generation of tests for genotyping hemophilia-causative rearrangements involving int22h and int1h hotspots in the factor VIII gene. J Thrombrosis Haemostasis. 2008;6:830–6.
Keeney et al. Practice guidelines for the molecular diagnosis of Haemophilia A. Clin Mol Genet Soc; 2005.
Richards-Yutz J, Grant K, Chao EC, Walther SE, Ganguly A. Update on molecular diagnosis oh hereditary hemorrhagic telangiectasia. Hum Genet. 2010;128(1):61–77.
Pruthi RK. Hemophilia: a practical approach to genetic testing. Mayo Clin Proc. 2005;80(11):1485–99.
Bossler AD, Richards J, George C, Godmilow L, Ganguly A. Novel mutations in ENG and ACVRL1 Identified in a series of 200 individuals undergoing clinical genetic testing of Hereditary Hemorrhagic Telangiectasia (HHT): correlation of genotype with phenotype. Hum Mutat. 2006;27(7):667–75.
Livak KJ, Schmittgen TD. Analyzing real-time PCR by the comparative Ct method. Nat Protoc. 2008;6:1101–8.
http://www.ncbi.nlm.nih.gov/projects/genome/probe/doc/TechQPCR.shtml
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 US Government
About this chapter
Cite this chapter
Purrazzella, J., Ganguly, A. (2012). Estimation of Exon Dosage Using Real-Time Quantitative Polymerase Chain Reaction. In: Hu, P., Hegde, M., Lennon, P. (eds) Modern Clinical Molecular Techniques. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2170-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2170-2_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2169-6
Online ISBN: 978-1-4614-2170-2
eBook Packages: MedicineMedicine (R0)